Interim Results

Swallowfield PLC 26 February 2004 Swallowfield plc Interim Results for the 28 weeks ended 10 January 2004 Chairman's Statement Results In our trading update of 7 January 2004, we highlighted a number of reasons why trading during the first half of the financial year was not as robust as we had originally expected. Turnover for the first 28 weeks of the year decreased by 29%, from £32.9m last year to £23.4m this year. The improvements we have made in our cost base, cash and net debt levels however, have limited the impact of this reduction and, consequently, profit before tax over the same period was £0.4m, compared with £0.7m last year. Turnover in the Cosmetics business decreased by 21% from £8.0m to £6.3m, but encouragingly, the operating loss was reduced from £0.5m to £0.3m. In the Aerosols business, turnover decreased 31% from £24.9m to £17.2m, and operating profit decreased from £1.4m to £0.8m. Both the general economic picture and the market background for our products have remained weak and, outside the retail food sector, this is reflected in the patchy Christmas trading updates from the major retailers. These factors, together with the significant customer delays noted in our trading update and the work we have undertaken to reduce our dependency on low value added products, have had an adverse impact on turnover. Despite these weak trading conditions, we have been successful in our recent efforts to reduce overhead costs, improve operating efficiencies and increase margins. We have reduced net operating expenses by £0.3m compared with the same period last year and increased overall gross profit by 2.8 percentage points. We expect these actions to have a greater positive impact on the results as the trading background begins to improve in our second half. Cash and Net Debt Net debt was reduced significantly during the period, from £8.8m at 30 June 2003, to £5.2m at 10 January 2004. Encouragingly, net debt was also £1.8m lower than at the same point last year and gearing improved to 44% compared with 59% at the same time last year. The net cash inflow of £3.6m, which has driven the improvement in net debt, is a result of the reduction in turnover, improved working capital management and the expected reduction in the high levels of capital investment undertaken in recent years. During the period under review, we have worked with our bankers to restructure our financing arrangements to better align our facilities with the Group's funding requirements. As a result of this refinancing, we have replaced our £6m term loan with a £6m revolving term loan, and increased our overdraft facility from £3.8m to £5.5m. The new facilities provide much better flexibility for our working capital cycle and have allowed us to obtain a reduction of 0.25% in the interest rate margin we pay. Strategy Update We are in the process of completing our strategic review of the business, and anticipate this being complete by the end of the first quarter of this calendar year. Part of our strategy will be to make greater use of Far Eastern sourcing routes as a means of reducing direct product costs, and we are in the process of setting up our own representative office in the People's Republic of China. We expect to make significant permanent savings in the medium and long term but there will be additional, one-off costs during the first 12 to 18 months of operation. Outlook The global economic environment appears to be improving, although the European economy and consumer spending are predicted to remain weak for some time. Accordingly, we anticipate consumer demand for our products to remain flat and pricing will remain under some pressure throughout the next 12 months. It is thus vital that we continue to improve our trading position through the development of innovative products and particularly the creation of products that give our customers a competitive advantage. In addition, we continue to examine ways to reduce costs and improve operating efficiencies. Against this background, we remain positive for the Group's prospects in the second half and expect trading to be close to current expectations. Recent contract wins and delivery of the delayed sales mentioned in our last trading update should enable the Aerosols business to show an improvement in trading performance compared to the same period last year. We also expect the Cosmetics business to have a much stronger trading performance in the second half of the current trading year. This expectation is supported by an order book, which is substantially higher than at the same time last year and we will continue to benefit from the overhead reductions made in the fourth quarter of last year. Given the nature of the sales pattern in the second half of the year, taken together with the structure of one of the main contracts we will fulfil during the same period, we expect to see a significant increase in working capital requirements between now and the year end. On this basis, we anticipate gearing levels at the end of the year to be broadly similar to those at the end of last year and our new financing arrangements have taken this into account. Dividend The Board is declaring an interim dividend of 2.8p per share, which is unchanged from that declared at the same time last year. Whilst this dividend is not fully covered, the approach of the Board is to maintain prudently the dividend payment in recognition of the reasonably good level of retained reserves and our confidence in the future of the business. The dividend will be paid on 27 May 2004 to shareholders on the register on 23 April 2004, and the shares will go ex dividend on 21 April 2004. J S Espey Chairman 26 February 2004 GROUP PROFIT & LOSS ACCOUNT 28 weeks 28 weeks 12 months ended ended ended 10 Jan 2004 11 Jan 2003 30 Jun 2003 (unaudited) (unaudited) Notes £'000 £'000 £'000 Turnover 1 23,433 32,888 54,663 Operating profit 1 588 904 1,419 Interest payable (218) (219) (444) Profit on ordinary activities before taxation 370 685 975 Tax on profit on ordinary activities (107) (205) (257) Profit attributable to shareholders 263 480 718 Dividends (316) (316) (541) Retained profit (53) 164 177 Dividend per ordinary share 3 2.8p 2.8p 4.8p Earnings per ordinary share - Basic 4 2.3p 4.3p 6.4p - Diluted 4 2.3p 4.3p 6.4p GROUP BALANCE SHEET As at As at As at 10 Jan 2004 11 Jan 2003 30 Jun 2003 (unaudited) (unaudited) £'000 £'000 £'000 Tangible fixed assets 12,682 13,568 13,174 Stocks 7,570 7,889 7,616 Debtors 5,632 7,882 9,267 Cash at bank and in hand 483 30 21 13,685 15,801 16,904 Creditors: amounts falling due within one year (8,474) (10,813) (11,032) Net current assets 5,211 4,988 5,872 Creditors: amounts falling due after more than one year (5,313) (6,003) (6,413) Provisions for liabilities and charges (844) (770) (844) 11,736 11,783 11,789 Share capital 563 563 563 Share premium 3,796 3,796 3,796 Reserves 7,377 7,424 7,430 Equity shareholders' funds 11,736 11,783 11,789 GROUP STATEMENT OF CASH FLOWS 28 weeks ended 28 weeks ended 12 months ended 10 Jan 2004 11 Jan 2003 30 Jun 2003 (unaudited) (unaudited) £'000 £'000 £'000 Net cash inflow from operating activities (note I) 4,512 1,918 1,069 Returns on investments and servicing of finance (218) (219) (444) Corporation tax paid (92) (532) (534) Capital expenditure: Purchase of tangible fixed assets (368) (3,055) (2,740) Sale of tangible fixed assets 40 25 53 Equity dividends paid (225) (225) (541) Net cash inflow/(outflow) before financing 3,649 (2,088) (3,137) Financing: (Decrease)/increase in long and short-term loans (1,532) 837 803 Capital element of finance lease rentals (200) (185) (406) (1,732) 652 397 Increase/(decrease) in cash 1,917 (1,436) (2,740) NOTES TO THE STATEMENT OF CASH FLOWS 28 weeks 28 weeks 12 months ended ended ended 30 Jun 2003 10 Jan 2004 11 Jan 2003 £'000 £'000 £'000 I. Reconciliation of operating profit to net cash inflow from operating activities Operating profit 588 904 1,419 Depreciation 822 614 1,492 (Profit) on disposal of fixed assets (2) (10) (17) Decrease in stocks 46 737 1,010 Decrease/(increase) in debtors 3,638 619 (763) (Decrease) in creditors (580) (946) (2,072) Net cash inflow from operating activities 4,512 1,918 1,069 II. Analysis of net debt Net cash at bank and in hand 483 30 21 Overdraft - (160) (1,455) Short-term loans (3) (669) (635) Long-term loans (4,500) (5,400) (5,400) Finance leases (1,165) (766) (1,365) (5,185) (6,965) (8,834) III. Reconciliation of net cash flow to movement in net debt Net debt at start of the period (8,834) (4,877) (4,877) Increase/(decrease) in cash 1,917 (1,436) (2,740) Decrease/(increase) in borrowings and finance leases 1,732 (652) (1,217) Net debt at end of the period (5,185) (6,965) (8,834) NOTES TO THE FINANCIAL INFORMATION 1. Turnover & segmental analysis 28 weeks ended 28 weeks ended 12 months ended 10 Jan 2004 11 Jan 2003 30 Jun 2003 Class of business Turnover Operating Turnover Operating Turnover Operating £'000 Profit £'000 Profit £'000 Profit £'000 £'000 £'000 Aerosol products 17,158 845 24,913 1,439 40,835 2,223 Cosmetic products 6,275 (257) 7,975 (535) 13,828 (804) 23,433 588 32,888 904 54,663 1,419 2. The results for the twenty-eight weeks ended 10 January 2004 and the summary balance sheet on that date are unaudited. The results for the 12 month period ended 30 June 2003 do not constitute full accounts within the meaning of section 240 of the Companies Act 1985. Full accounts for that period together with an unqualified audit report thereon have been filed with the Registrar of Companies. 3. The dividend comprises an ordinary dividend of 2.8p (2003: 2.8p) per ordinary share payable on 27 May 2004 to shareholders on the register on 23 April 2004. 4. The calculation of basic earnings per share is based on 11,256,416 (2003: 11,256,416) ordinary shares of 5.0p each, being the weighted average number of ordinary shares in issue during the period, and the profit on ordinary activities after taxation of £263,000 (2003: £480,000). The diluted earnings per share is based on the profit for the period of £263,000 (2003: £480,000) and on the weighted average number of shares in issue for the period adjusted for shares held under unexercised options. The adjusted number of shares for the period was 11,266,316 (2003: 11,275,959) ordinary shares which include 9,900 (2003: 19,543) dilutive potential ordinary shares from executive share options. 5. The Interim Report will be sent to shareholders and is available to members of the public at the Company's Registered Office at Swallowfield House, Station Road, Wellington, Somerset TA21 8NL. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings